In line with these data, osteoprogenitors treated with PCa-EVs in vitro showed low expression of Bmp2 and Runx2, two genes that are the main targets of miR-30e-5p, miR-26a-5p, and miR-27a-3p (Figure 5d,e). This evidence concerns the gene BMP2 and posterior cortical atrophy.